1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Glassia 1.4.3 Aralast NP 1.4.4 Prolastin C 1.4.5 Others 1.5 Market by Application 1.5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Specialty Clinics 1.6 Coronavirus Disease 2019 (Covid-19): Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Impact 1.6.1 How the Covid-19 is Affecting the Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry 1.6.1.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Alpha-1 Antitrypsin Deficiency Augmentation Therapy Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2015-2026) 2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Regions 2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Market Size 3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2015-2020) 3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio 3.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2019 3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served 3.4 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service 3.5 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2015-2020) 4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2021-2026) 5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application (2015-2026) 5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) 5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2015-2020) 6.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in North America (2019-2020) 6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) 6.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2015-2020) 7.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Europe (2019-2020) 7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) 7.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2015-2020) 8.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) 8.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Grifols 9.1.1 Grifols Company Details 9.1.2 Grifols Business Overview and Its Total Revenue 9.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 9.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020)) 9.1.5 Grifols Recent Development 9.2 CSL 9.2.1 CSL Company Details 9.2.2 CSL Business Overview and Its Total Revenue 9.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 9.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) 9.2.5 CSL Recent Development 9.3 Baxter 9.3.1 Baxter Company Details 9.3.2 Baxter Business Overview and Its Total Revenue 9.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 9.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) 9.3.5 Baxter Recent Development 9.4 Kamada 9.4.1 Kamada Company Details 9.4.2 Kamada Business Overview and Its Total Revenue 9.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 9.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) 9.4.5 Kamada Recent Development 9.5 Takeda 9.5.1 Takeda Company Details 9.5.2 Takeda Business Overview and Its Total Revenue 9.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 9.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) 9.5.5 Takeda Recent Development 9.6 Abeona 9.6.1 Abeona Company Details 9.6.2 Abeona Business Overview and Its Total Revenue 9.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 9.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) 9.6.5 Abeona Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Table 3. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Glassia Table 6. Key Players of Aralast NP Table 7. Key Players of Prolastin C Table 8. Key Players of Others Table 9. COVID-19 Impact Global Market: (Four Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players to Combat Covid-19 Impact Table 14. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions (2015-2020) Table 18. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Strategy Table 24. Main Points Interviewed from Key Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2015-2020) (Million US$) Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players (2015-2020) Table 27. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2019) Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service Table 31. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) (Million US$) Table 34. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Type (2015-2020) Table 35. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2021-2026) Table 36. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Application (2015-2020) Table 37. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) (Million US$) Table 38. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Application (2021-2026) Table 39. North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2019-2020) (Million US$) Table 40. North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2019-2020) Table 41. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) (Million US$) Table 42. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2015-2020) Table 43. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) (Million US$) Table 44. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2015-2020) Table 45. Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2019-2020) Table 47. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) (Million US$) Table 48. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2015-2020) Table 49. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) (Million US$) Table 50. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2015-2020) Table 51. Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2019-2020) (Million US$) Table 52. Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2019-2020) Table 53. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2015-2020) (Million US$) Table 54. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2015-2020) Table 55. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2015-2020) (Million US$) Table 56. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2015-2020) Table 57. Grifols Company Details Table 58. Grifols Business Overview Table 59. Grifols Product Table 60. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) (Million US$) Table 61. Grifols Recent Development Table 62. CSL Company Details Table 63. CSL Business Overview Table 64. CSL Product Table 65. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) (Million US$) Table 66. CSL Recent Development Table 67. Baxter Company Details Table 68. Baxter Business Overview Table 69. Baxter Product Table 70. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) (Million US$) Table 71. Baxter Recent Development Table 72. Kamada Company Details Table 73. Kamada Business Overview Table 74. Kamada Product Table 75. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) (Million US$) Table 76. Kamada Recent Development Table 77. Takeda Company Details Table 78. Takeda Business Overview Table 79. Takeda Product Table 80. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) (Million US$) Table 81. Takeda Recent Development Table 82. Abeona Company Details Table 83. Abeona Business Overview Table 84. Abeona Product Table 85. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) (Million US$) Table 86. Abeona Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2020 VS 2026 Figure 2. Glassia Features Figure 3. Aralast NP Features Figure 4. Prolastin C Features Figure 5. Others Features Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Case Studies Figure 8. Specialty Clinics Case Studies Figure 9. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered Figure 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2019 Figure 15. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2019 Figure 17. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 21. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) Figure 22. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) Figure 24. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) Figure 26. Kamada Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) Figure 28. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) Figure 30. Abeona Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2015-2020) Figure 32. Bottom-up and Top-down Approaches for This Report Figure 33. Data Triangulation Figure 34. Key Executives Interviewed

Grifols CSL Baxter Kamada Takeda Abeona